Targeting IL‐17 Presents a Promising Strategy for Treating Diseases Related to the Dysregulation of Lipid Homeostasis

Lipids are fundamental constituents of cell membranes and play a crucial role in signaling pathways that regulate a wide array of cellular functions. Consequently, the dysregulation of lipid homeostasis is recognized as a significant contributor to metabolic diseases. Given the limitations of current strategies for regulating lipid metabolism, it is essential to explore innovative approaches to modulate lipid homeostasis to effectively address diseases associated with its dysregulation. Inflammation plays a critical role in the regulation of lipid metabolism, acting through various pathways and mechanisms that influence both lipid synthesis and degradation. The involvement of Interleukin‐17 (IL‐17) in inflammatory responses is particularly noteworthy, as recent studies have highlighted its impact on lipid metabolism, particularly in the context of obesity and metabolic disorders. This review critically examines the IL‐17 signaling pathway, elucidates the mechanisms by which IL‐17 affects lipid metabolism, and explores the therapeutic potential of targeting IL‐17 in the treatment of disorders related to lipid homeostasis. This review underscores the promise of targeting IL‐17 signaling pathways as a therapeutic strategy for addressing the dysregulation in lipid homeostasis.